{
  "raw_answer": "On page 2, under \"Patients and Methods\" and the subheading \"Subjects\", the document states:\n\"The study subjects were 308 Japanese patients (300 index patients) with ADPD (age at disease onset [AAO; mean ± SD], 51.1 ± 11.7 years; range, 8-83 years...)\"\n\nPatient AII-11 is described as a patient with ADPD (Autosomal Dominant Parkinson's Disease), as shown in Figure 1A on page 3 and Table 2 which lists AII-11 under \"Patient ID\".\n\nTherefore, the lower age limit for study inclusion for ADPD patients (the group patient AII-11 belongs to), based on age at disease onset, is 8 years.\n\nThe lower age limit for study inclusion, based on age at disease onset for patients with ADPD (which includes patient AII-11 from Family A), is 8 years.",
  "question": "Regarding patient 'AII-11' from family 'Family A': What is the lower age limit for study inclusion (if any)?",
  "context": "Based *only* on the information contained within the provided document, answer the following question:\n\nRegarding patient 'AII-11' from family 'Family A': What is the lower age limit for study inclusion (if any)?\n\nIf the information is not found in the document, state 'Information not found'."
}